Skip to main content

Nociceptive Pain

0
Pipeline Programs
3
Companies
4
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Eppendorf
EppendorfGermany - Hamburg
2 programs
NOLN/A1 trial
SPIN/A1 trial
Active Trials
NCT06905340Recruiting240Est. Jan 2026
NCT06040307Completed80Est. May 2024
Medasense Biometrics
Medasense BiometricsIsrael - Ramat Gan
1 program
NOL Guided AnalgesiaN/A1 trial
Active Trials
NCT04305015Completed26Est. Dec 2020
Presidio Medical
Presidio MedicalCA - South SF
1 program
ULF therapyN/A1 trial
Active Trials
NCT06763653Recruiting303Est. Apr 2029

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
EppendorfNOL
Presidio MedicalULF therapy
EppendorfSPI
Medasense BiometricsNOL Guided Analgesia

Clinical Trials (4)

Total enrollment: 649 patients across 4 trials

NCT06905340EppendorfNOL

Guiding Opioid Administration by Nociception Level Index (NOL) in Patients With Regional Anesthesia

Start: May 2025Est. completion: Jan 2026240 patients
N/ARecruiting
NCT06763653Presidio MedicalULF therapy

Ultra Low Frequency Neuromodulation for Nociceptive Chronic Low Back Pain

Start: Jan 2025Est. completion: Apr 2029303 patients
N/ARecruiting
NCT06040307EppendorfSPI

Guiding Opioid Administration in Patients With Regional Anesthesia

Start: Dec 2023Est. completion: May 202480 patients
N/ACompleted
NCT04305015Medasense BiometricsNOL Guided Analgesia

Postoperative Benefits of Intraoperative Nociception Level (NOL) Titration - Pilot

Start: Nov 2020Est. completion: Dec 202026 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 649 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.